Terms: = Prostate cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Diagnosis
33 results:
1. Urinary fatty acid biomarkers for prostate cancer detection.
Noriega Landa E; Quaye GE; Su X; Badmos S; Holbrook KL; Polascik TJ; Adams ES; Deivasigamani S; Gao Q; Annabi MH; Habib A; Lee WY
PLoS One; 2024; 19(2):e0297615. PubMed ID: 38335180
[TBL] [Abstract] [Full Text] [Related]
2. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract] [Full Text] [Related]
3. A critical analysis of deficiencies in the quality of information contained in prostate multiparametric MRI requests and reports.
Cullivan O; Roche E; Hegazy M; Taha M; Durkan G; O'Malley P; McCarthy P; Dowling CM
Ir J Med Sci; 2023 Feb; 192(1):27-31. PubMed ID: 35094231
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model.
Getaneh AM; Heijnsdijk EA; de Koning HJ
Cancer Med; 2021 Jun; 10(12):4046-4053. PubMed ID: 33991077
[TBL] [Abstract] [Full Text] [Related]
5. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
Steinberg RL; Rasmussen RG; Johnson BA; Ghandour R; De Leon AD; Xi Y; Yokoo T; Kim S; Kapur P; Cadeddu JA; Pedrosa I
Eur Radiol; 2021 Jan; 31(1):314-324. PubMed ID: 32770377
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone prostate cancers.
Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
[No Abstract] [Full Text] [Related]
7. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
8. Extensive serum cytokine analysis in patients with prostate cancer.
Gong D; Wang Y; Wang Y; Chen X; Chen S; Wang R; Liu L; Duan C; Luo S
Cytokine; 2020 Jan; 125():154810. PubMed ID: 31430659
[TBL] [Abstract] [Full Text] [Related]
9. Zyxin: a mechanotransductor to regulate gene expression.
Wang YX; Wang DY; Guo YC; Guo J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):413-425. PubMed ID: 30657586
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454
[TBL] [Abstract] [Full Text] [Related]
11. Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment.
Liu C; Liu SL; Wang ZX; Yu K; Feng CX; Ke Z; Wang L; Zeng XY
Asian J Androl; 2018; 20(5):459-464. PubMed ID: 29667616
[TBL] [Abstract] [Full Text] [Related]
12. Validation of prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in prostate cancer diagnosis.
Kim SH; Choi MS; Kim MJ; Kim YH; Cho SH
AJR Am J Roentgenol; 2017 Oct; 209(4):800-805. PubMed ID: 28705064
[TBL] [Abstract] [Full Text] [Related]
13. Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study.
Oya M; Tomita Y; Fukasawa S; Shinohara N; Habuchi T; Rini BI; Fujii Y; Kamei Y; Umeyama Y; Bair AH; Uemura H
Cancer Sci; 2017 Jun; 108(6):1231-1239. PubMed ID: 28267243
[TBL] [Abstract] [Full Text] [Related]
14. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk prostate cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract] [Full Text] [Related]
15. Genetic variants in RNA-induced silencing complex genes and prostate cancer.
Nikolić Z; Savić Pavićević D; Vučić N; Cerović S; Vukotić V; Brajušković G
World J Urol; 2017 Apr; 35(4):613-624. PubMed ID: 27498138
[TBL] [Abstract] [Full Text] [Related]
16. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
[TBL] [Abstract] [Full Text] [Related]
17. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study.
Panebianco V; Barchetti F; Sciarra A; Ciardi A; Indino EL; Papalia R; Gallucci M; Tombolini V; Gentile V; Catalano C
Urol Oncol; 2015 Jan; 33(1):17.e1-17.e7. PubMed ID: 25443268
[TBL] [Abstract] [Full Text] [Related]
18. Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer.
Kotb S; Mosharafa A; Essawi M; Hassan H; Meshref A; Morsy A
Tumour Biol; 2014 Dec; 35(12):12613-7. PubMed ID: 25190021
[TBL] [Abstract] [Full Text] [Related]
19. Electronic health record-based triggers to detect potential delays in cancer diagnosis.
Murphy DR; Laxmisan A; Reis BA; Thomas EJ; Esquivel A; Forjuoh SN; Parikh R; Khan MM; Singh H
BMJ Qual Saf; 2014 Jan; 23(1):8-16. PubMed ID: 23873756
[TBL] [Abstract] [Full Text] [Related]
20. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract] [Full Text] [Related]
[Next]
